Vertical Alveolar Bone Loss
Conditions
Brief summary
Study of the effectiveness of the application of regenerative therapy with autogenous, platelet-rich plasma in vertical defects Investigation of the effectiveness of the application of regenerative therapy with enamel matrix derivatives in vertical bone defects Study of the effectiveness of the application of guided tissue regeneration in vertical bone defects with Barrier membrane and Barrier membrane and autogenous platelet-rich plasma
Interventions
regenerative therapy with PRP for vertical bone defects
regenerative therapy with EMD for vertical bone defects
guided tissue regeneration with barrier membrane alone for vertical bone defects
guided tissue regeneration with barrier membrane and PRP for vertical bone defects
Sponsors
Study design
Eligibility
Inclusion criteria
* good oral hygiene * written informed consent * age * no systemic diseases
Exclusion criteria
* smokers * horizontal bone loss * untreated periodontium disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Probing depth in mm | 6 months |
| Level of Margo Gingivalis in mm | 6 months |
| Clinical attachment level in mm | 6 months |
| The distance from the ECJ to the base of the bone defect in mm | 6 months |
| The distance from the ECJ to the apex of the bone defect in mm | 6 months |
| The width of the bone defect in mm | 6 months |
Countries
Bulgaria